Merck Scores A First With Keytruda Under Australia's Provisional Pathway
Executive Summary
The Therapeutic Goods Administration has provisionally approved new uses of the anticancer medicine based on early clinical data.
You may also be interested in...
Eli Lilly's Oncology Drug Is First Candidate For Australia's New Provisional Approval Pathway
Australia gets the ball rolling on its new pathway for provisional approval of innovative prescription medicines.
Eligibility Decisions Near For Australia’s New Provisional Pathway
The first registration of a medicine under Australia’s new provisional approval pathway could take place at the end of this year, according to plans by the Therapeutic Goods Administration.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.